Living-donor kidney transplantation: A review of the current practices for the live donor

Journal of the American Society of Nephrology

Volumn 16, Issue 7, 2005, Pages 2098-2110

  Davis, Connie L ^a,c   Delmonico, Francis L ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

APHERESIS; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; DONOR SELECTION; GRAFT SURVIVAL; HEALTH INSURANCE; HLA SYSTEM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHRECTOMY; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; CHRONIC KIDNEY FAILURE;

HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS;

EID: 27744542006     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004100824     Document Type: Review

References (82)

1. Price D: Living kidney donation in Europe: Legal and ethical perspectives-the EUROTOLD Project. Transpl Int 7[Suppl 1]: S665-S667, 1994
2. McAlister VC, Badovinac K: Transplantation in Canada: Report of the Canadian Organ Replacement Register. Transplant Proc 35: 2428-2430, 2003
3. Shiohira Y, Iseki K, Kowatari T, Uehara H, Yoshihara K, Nishime K, Arakaki Y: A community-based evaluation of the effect of renal transplantation on survival in patients with renal-replacement therapy. Nippon Jinzo Gakkai Shi 38: 449-454, 1996
4. OPTN/SRTR Annual Report 2004. Available: www.optn.org/AR2004/default.htm
5. Delmonic FL, Sheehy E, Marks WH, Baliga P, McGowan JJ, Magee JC: Organ donation and utilization in the United States, 2004. Am J Transplant 5: 862-873, 2005
6. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 74: 1377-1381, 2002
7. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344: 726-731, 2001
8. OPTN/SRTR Annual Report 2003, Table 2.8. Available: www.optn.org
9. OPTN/SRTR Annual Report 2003, Table 5.9b. Available: www.optn.org
10. Cecka JM: The OPTN/UNOS Renal Transplant Registry. Clin Transpl 1-12, 2003
11. Gjertson DW: Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002. Clin Transpl 337-386, 2003
12. OPTN/SRTR Annual Report 2003, Table 2.9. Available: www.optn.org
13. Kayler LK, Rasmussen CS, Dykstra DM, Ojo AO, Port FK, Wolkfe RA, Merion RM: Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant 3: 452-458, 2003
14. Tankersley MF, Gaston RS, Curtis JJ, Julian BA, Deierhoi MH, Zeigler ST, Diethelm AG: The living donor process in kidney transplantation: Influence of race and comorbidity. Transplant Proc 29: 3722-3723, 1997
15. Abecassis M, Adams M, Adams P, Arnold RM, Atkins CR, Barr ML, Bennett WM, Bia MJ, Briscoe DM, Burdick J, Corry RJ, Davis J, Delmonico FL, Gaston RS, Harmon W, Jacobs CL, Kahn J, Leichtman AB, Miller C, Moss D, Newmann JM, Rosen LS, Siminoff L, Spital A, Starnes VA, Thomas C, Tyler LS, Williams L, Wright FH, Youngner S, Group LODC: Consensus statement on the live organ donor. JAMA 284: 2919-2926, 2000
16. Adams P, Cohen DJ, Danovitch GM, Edington RM, Gaston RS, Jacobs CL, Luskin RS, Metzger RA, Peters TG, Siminoff LA, Veatch RM, Rothberg-Wegman L, Bartlett ST, Brigham L, Burdick J, Gunderson S, Harman W, Matas AJ, Thistlethwaite JR, Delmonico FL: The nondirected live-kidney donor: Ethical considerations and practice guidelines: A National Conference Report. Transplantation 74: 582-589, 2002
17. Delmonico FL: Exchanging kidneys-Advances in living-donor transplantation. N Engl J Med 350: 1812-1814, 2004
18. Roth AE, Sonmez T, Unver MU: Kidney exchange. Q J Economics 119: 457-488, 2004
19. Park K, Moon JI, Kim SI, Kim YS: Exchange donor program in kidney transplantation. Transplantation 67: 336-338, 1999
20. Kranenburg LW, Visak T, Weimar W, Zuidema W, de Klerk M, Hilhorst M, Passchier J, IJzermans JN, Busschbach JJ: Starting a crossover kidney transplantation program in the Netherlands: Ethical and psychological considerations. Transplantation 78: 194-197, 2004
21. Ross LF, Zenios S: Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit. Transplantation 78: 641-646, 2004
22. Spital A: Donor exchange for renal transplantation. N Engl J Med 351: 935-937; author reply 935-937, 2004
23. Ritsch ME: Intended Recipient Exchanges, Paired Exchanges and NOTA 301. Kidney & Pancreas Transplantation Committee report to OPTN/UNOS board of Directors, Richmond, Williams Mullen, 2003
24. Jacobs CL, Roman D, Garvey C, Kahn J, Matas AJ: Twenty-two nondirected kidney donors: An update on a single center's experience. Am J Transplant 4: 1110-1116, 2004
25. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan SC, Kobashigawa J, Kupiec-Weglinski J, Matas AJ, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan DB, Delmonico FL: National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1003-1041, 2004
26. Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K: Long-term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 65: 224-228, 1998
27. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, Larson TS, Griffin MD, Textor SC, Velosa JA, Schwab TR, Fix LA, Stegall MD: Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3: 1017-1023, 2003
28. Montgomery RA, Cooper M, Kraus E, Rabb H, Samaniego M, Simpkins CE, Sonnenday CJ, Ugarte RM, Warren DS, Zachary AA: Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl 199-213, 2003
29. Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, Grande JP, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Velosa JA, Textor SC, Platt JL, Stegall MD: ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75: 971-977, 2003
30. Gloor JM, DeGoey SR, Griffin MD, Larson TS, Lager DJ, Fidler ME, Moore SB, Stegall MD: Living donor kidney transplantation with and without splenectomy in positive crossmatch patients. Am J Transplant 4: 258, 2004
31. Simpkins CE, Zachary AA, Cooper M, Warren DS, Ratner LE, Montgomery RA: Improved results with selective use of splenectomy and anti-CD-20 for positive crossmatch transplants. Am J Transplant 4: 550, 2004
32. Schweitzer EJ, Wilson JS, Jacobs S, Machan CH, Philosophe B, Farney A, Colonna J, Jarrell B, Bartlett ST: Increased rates of donation with laparoscopic donor nephrectomy. Ann Surg 232: 392-400, 2000
33. Ratner LE, Montgomery RA, Kavoussi LR: Laparoscopic live donor nephrectomy. A review of the first 5 years. Urol Clin North Am 28: 709-719, 2001
34. Greenstein MA, Harkaway R, Badosa F, Ginsberg P, Yang SL: Minimal incision living donor nephrectomy compared to the hand-assisted laparoscopic living donor nephrectomy. World J Urol 20: 356-359, 2003
35. Jacobs SC, Cho E, Foster C, Liao P, Bartlett ST: Laparoscopic donor nephrectomy: The University of Maryland 6-year experience. J Urol 171: 47-51, 2004
36. Simon SD, Castle EP, Ferrigni RG, Lamm DL, Swanson SK, Novicki DE, Andrews PE: Complications of laparoscopic nephrectomy: The Mayo Clinic experience. J Urol 171: 1447-1450, 2004
37. El-Galley R, Hood N, Young CJ, Deierhoi MH, Urgan DA: Donor nephrectomy: A comparison of techniques and results of open, hand assisted and full laparoscopic nephrectomy. J Urol 171: 40-43, 2004
38. Najarian JS, Chavers BM, McHugh LE, Matas AJ: 20 years or more of follow-up of living kidney donors. Lancet 340: 807-810, 1992
39. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL: Morbidity and mortality after living kidney donation, 1999-2001: Survey of United States transplant centers. Am J Transplant 3: 830-834, 2003
40. Narkun-Burgess DM, Nolan CR, Norman JE, Page WF, Miller PL, Meyer TW: Forty-five year follow-up after uninephrectomy. Kidney Int 43: 1110-1115, 1993
41. Fehrman-Ekholm I, Blinder CG, Stenbeck M, Tyden G, Groth CG: Kidney donors live longer. Transplantation 64: 976-978, 1997
42. Ramcharan T, Matas AJ: Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2: 959-964, 2002
43. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM: Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 74: 1349-1351, 2002
44. Kasiske BL, Ma JZ, Louis TA, Swan SK: Long-term effects of reduced renal mass in humans. Kidney Int 48: 814-819, 1995
45. Delmonico FL: A report of the Amsterdam forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 79[Suppl]: S53-S66, 2005
46. Delmonico FL: The consensus statement of the Amsterdam Forum on the care of the live kidney donor. Transplantation 78: 491-492, 2004
47. Kapoor A, Kapoor A, Majajan G, Singh A, Sarin P: Multispiral computed tomographic angiography of renal arteries of live potential renal donors: A review of 118 cases. Transplantation 77: 1535-1539, 2004
48. Bia MJ, Ramos EL, Danovitch GM, Gaston RS, Harmon WE, Leichtman AB, Lundin PA, Neylan J, Kasiske BL: Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 60: 322-327, 1995
49. Gabolde M, Herve C, Moulin AM: Evaluation, selection, and follow-up of live kidney donors: A review of current practice in French renal transplant centres. Nephrol Dial Transplant 16: 2048-2052, 2001
50. Piepsz A, Pintelon H, Ham HR: Estimation of normal chromium-51 ethylenediamine tetraacetic acid clearance in children. Eur J Nucl Med 21: 12-16, 1994
51. Davies DF, Shock MW: Age changes in glomerular filtrations rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 29: 496-507, 1950
52. Gonwa TA, Atkins C, Zhang YA, Parker TF, Hunt JM, Lu CY, White MG: Glomerular filtration rates in persons evaluated as living-related donors-Are our standards too high? Transplantation 55: 983-985, 1993
53. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS: Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 43: 112-119, 2004
54. Ozdemir N, Guz G, Muderrisoglu H, Demirag A, Arat Z, Pekkara O, Haberal M: Ambulatory blood pressure monitoring in potential renal transplant donors. Transplant Proc 31: 3369-3370, 1999
55. Textor SC, Taylor SJ, Larson TS, Prieto M, Griffin MD, Gloor JM, Nyberg SL, Velosa JA, Schwab TR, Stegall MD: Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol 14: 2159-2167, 2003
56. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor JM, Griffin MD, Cosio FG, Schwab TR, Prieto M, Nyberg SL, Ishitani M, Stegall MD: Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 78: 276-282, 2004
57. Torres VE, Offord KP, Anderson CF, Velosa JA, Frohnert PP, Donadio JV Jr, Wilson DM: Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int 31: 1383-1390, 1987
58. Wang YY, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: New challenges of the old problem. Arch Intern Med 164: 2126-2134, 2004
59. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y, Diaz-Gonzalez R, Rodicio JL: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney M 58: 2111-2118, 2000
60. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Influence of smoking and obesity on the development of proteinuria. Kidney Int 62: 956-962, 2002
61. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63: 1468-1474, 2003
62. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
63. Adelman RD, Restaino IG, Alon US, Blowey DL: Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 138: 481-485, 2001
64. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004
65. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992-1997, 1999
66. Klausen L, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS: Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35, 2004
67. Lee YH, Huang WC, Chang LS, Chen MT, Yang YF, Huang JK: The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol 152: 1386-1388, 1994
68. Wahlander K, Larson G, Lindahl TL, Andersson C, Firison L, Gustafsson D, Bylock A, Eriksson BI: Factor V Leiden (G1691A and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 87: 580-585, 2002
69. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G: The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 341: 801-806, 1999
70. Samuelsson E, Hagg S: Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand 83: 674-681, 2004
71. Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled "hypertensive nephrosclerosis." J Hypertens 22: 1051-1055, 2004
72. Satko SG, Freedman BI: The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 13: 337-344, 2004
73. Barbari A, Stephan A, Masri M, Karam A, Aoun S, El Nahas J, Bou Khalil J: Consanguinity-associated kidney diseases in Lebanon: An epidemiological study. Mol Immunol 39: 1109-1114, 2003
74. O'Brien PE, Dixon JB: The extent of the problem of obesity. Am J Surg 184: 4S-8S, 2002
75. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291: 2847-2850, 2004
76. Okosun IS, Chandra KM, Boev A, Boltri JM, Choi ST, Parish DC, Dever GE: Abdominal adiposity in US adults: Prevalence and trends, 1960-2000. Prev Med 39: 197-206, 2000
77. Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM: Five-year obesity incidence in the transition period between adolescence and adulthood: The National Longitudinal Study of Adolescent Health. Am J Clin Nutr 80: 569-575, 2004
78. Storey ML, Forshee RA, Weaver AR, Sansalone WR: Demographic and lifestyle factors associated with body mass index among children and adolescents. Int J Food Sci Nutr 54: 491-503, 2003
79. Goran MI, Ball GD, Cruz ML: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 88: 1417-1427, 2003
80. Goran MI, Treuth MS: Energy expenditure, physical activity, and obesity in children. Pediatr Clin North Am 48: 931-953, 2001
81. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348: 1625-1638, 2003
82. Calle EE, Thun MJ: Obesity and cancer. Oncogene 23: 6365-6378, 2004